GE HealthCare Technologies (GEHC) EBITDA Margin (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly EBITDA Margin came in at 13.96% in Q2 2026, up 89.0% YoY from 7.38% in Q2 2025, and up 39.05% on a QoQ basis from 10.04% in Q1 2026.
GE HealthCare Technologies (GEHC) EBITDA Margin (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of EBITDA Margin data on file, last reported at 13.96% in Q2 2026.
- Quarterly EBITDA Margin rose 89.0% year-over-year to 13.96% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 12.86% (down 97.0% YoY) and the FY2025 annual result came in at 13.4%, up 5.0% from the prior year.
- EBITDA Margin improved to 13.96% in Q2 2026, from 10.04% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 15.74% in Q4 2022 to a low of 10.04% in Q1 2026.
- A 5-year average of 13.06% and a median of 13.11% in 2025 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2024 — EBITDA Margin surged 182 bps — and 2026, when it sank 313 bps.
- Tracing GEHC's EBITDA Margin over 5 years: stood at 15.74% in 2022, then decreased by 16 bps to 13.23% in 2023, then gained by 14 bps to 15.06% in 2024, then declined by 4 bps to 14.51% in 2025, then declined by 4 bps to 13.96% in 2026.
- The last three EBITDA Margin figures came in at 13.96% (Q2 2026), 10.04% (Q1 2026), and 14.51% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 19.15% |
| 10 | Zimmer Biomet Holdings | 19.32 Bn | 18.91 Bn | 1.54 Bn | 14.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.96% |
| Mar 31, 2026 | 10.04% |
| Dec 31, 2025 | 14.51% |
| Sep 30, 2025 | 12.70% |
| Jun 30, 2025 | 13.06% |
| Mar 31, 2025 | 13.17% |
| Dec 31, 2024 | 15.06% |
| Sep 30, 2024 | 13.90% |
| Jun 30, 2024 | 12.56% |
| Mar 31, 2024 | 11.61% |
| Dec 31, 2023 | 13.23% |
| Sep 30, 2023 | 12.80% |
| Jun 30, 2023 | 11.83% |
| Mar 31, 2023 | 11.88% |
| Dec 31, 2022 | 15.74% |
| Sep 30, 2022 | 13.22% |
| Jun 30, 2022 | 14.07% |
| Mar 31, 2022 | 11.72% |